Public Company News

Market update: Strong tanker market due to sanctions and high demand for oil - Concordia Maritime

GÖTEBORG, Sweden, June 6, 2022 /PRNewswire/ -- The product tanker market has strengthened significantly during April and May, with market rates at much higher levels than for both Q1 2022 and the full year 2021. At the end of May, average spot market earnings for an MR vessel (clean) was about$36...

2022-06-06 13:39 2948

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...

2022-06-06 13:15 4174

Poster Highlighting Phase II Clinical Study of KN026 for HER2-expressing Advanced GC/GEJ Presented at 2022 ASCO

SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that data from a phase II clinical study of KN026 (HER2 bispecific antibody) monotherapy in patients with previously treated, advance...

2022-06-06 10:49 3397

Research Updates on KN046 Presented at 2022 ASCO

SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that research updates from four clinical studies of KN046 (PD-L1/CTLA-4 bispecific antibody) presented as a poster or published online at the 2022 American Society of Clinical Oncology Annual Meeting (20...

2022-06-06 09:47 3578

SocietyOne launches transaction & savings accounts powered by Westpac

SYDNEY, June 6, 2022 /PRNewswire/ -- In its first major corporate milestone following its acquisition by MONEYME Ltd (ASX:MME), digital finance platform SocietyOne has launched transaction and savings accounts powered by Westpac's Banking-as-a-Service (BaaS).

2022-06-06 09:25 4047

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

* WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-filled syringes (PFS) capacity to 17 million units per year. * WuXi Biologics has established a global manufacturing network with 9 drug p...

2022-06-06 08:30 4860

Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-06-06 08:08 3877

Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-06-06 08:00 3952

Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, June 6, 2022  /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-06-06 08:00 3696

Angel Yeast Increases New Energy Procurement in Green Push to Curb Carbon Emission

YICHANG, China, June 5, 2022 /PRNewswire/ -- Angel Yeast (en.angelyeast.com) (SH600298), a listed global yeast and yeast extract manufacturer, is glad to announce that the Company has been granted the green electricity certificate issued and certified by China Hubei Power Exchange Center and Chin...

2022-06-05 21:00 5475

JW Therapeutics Presents Latest Data of Carteyva® at 2022 ASCO Annual Meeting

SHANGHAI, June 5, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, presented the latest data of three clinical studies on Carteyva® (relmacabtagene autoleuce...

2022-06-05 18:30 5486

CStone presents updated results of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC) at ASCO 2022

* Nofazinlimab in combination with lenvatinib as first-line treatment for unresectable hepatocellular carcinoma demonstrated an objective response rate of 45.0%. The median duration of response was not yet reached as of the data cutoff date (4.2 to 18.7+ months). The median progression free sur...

2022-06-05 08:02 6060

Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients

FOSTER CITY, Calif. and SHANGHAI, June 4, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announces today that its licensing partner, Gilead Sciences, Inc. (Nasdaq: GILD), reported positive results from the primary analysis of the Phase 3 TROPiCS-02 study of Trodelvy® (sacituzumab govitecan...

2022-06-04 20:30 7382

CStone presents clinical results of sugemalimab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma via an oral abstract session at ASCO 2022

* GEMSTONE-201 is the largest registrational clinical study of an anti-PD-(L)1 antibody reported so far in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL). * Results on the primary endpoint showed that sugemalimab significantly improved objective res...

2022-06-04 08:02 8211

KT SAT to participate Communic Asia 2022 showcasing its service competitiveness

SEOUL, South Korea, June 3, 2022 /PRNewswire/ -- KT SAT, South Korea's the sole satellite service company with its self-owned satellites, participated in Communic Asia 2022,Asia's leading technology trade show held in Singapore Expo from 1st to 3rd, June.

2022-06-03 14:45 14017

SCB powers its path toward digital banking leadership and new era of API-led modernized banking platforms with IBM

* SCB's continuous investment in its IT infrastructure today ensures millions of its customers nationwide can enjoy exceptional services and products. BANGKOK ,June 3, 2022 /PRNewswire/ -- SCB announced today the adoption of IBM zSystems (NYSE:IBM), bringing the highly secured, high availability...

2022-06-03 12:41 10173

XCMG Consolidates Sustainable Development with New Energy-Centric Strategies During World Environment Day 2022

XUZHOU, China, June 3, 2022 /PRNewswire/ -- XCMG (SHE:000425) has obtained the first "green license" inChina's construction crane sector in May for its XCT25PHEV hybrid crane, which is the first "true hybrid" model in the world. It was developed over the course of five years and underwent another...

2022-06-03 11:58 5655

Mitratel Announces Share Buyback of IDR 1 Trillion

JAKARTA, Indonesia, June 3, 2022 /PR Newswire/ -- PT Dayamitra Telekomunikasi Tbk (Mitratel) IDX: MTEL announced plan to carry out share buyback with the maximum amount ofIDR 1 trillion or about 5.3% of its paid-up capital. This corporate action will be implemented within three months following i...

2022-06-03 10:29 5131

Positive Response from Game Users Following the Update for P&E Game 'DARK EDEN M ON WEMIX'

* Increase in userbase and game activity after first update of P&E game 'DARK EDEN M on WEMIX' * Entertaining P&E elements added through gameplay and token economy due to increase in active users and stabilization * Results of an update that improved convenience for obtaining and using item...

2022-06-03 10:00 4987

1 Hotel San Francisco is Now Open

The Property is the Brand's Seventh Location Globally SAN FRANCISCO, June 2, 2022 /PRNewswire/ -- 1 Hotels, the luxury lifestyle hotel brand inspired by nature, today announced the opening of 1 Hotel San Francisco, the mission-driven luxury hospitality brand's secondCalifornia property and the C...

2022-06-02 23:00 2078
1 ... 732733734735736737738 ... 902

Week's Top Stories